)
Jupiter Life Line Hospitals (JLHL) investor relations material
Jupiter Life Line Hospitals Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
FY 2026 marked milestones with early commissioning of Dombivli hospital ahead of schedule and on budget, acquisition of BKC land for a 400-bed hospital, and expansion to four hospitals in MMR, two in Pune, and one in Indore.
The expansion strategy focuses on asset-heavy, owned infrastructure in densely populated urban areas, aiming for long-term operational stability and leadership in Western India.
Approved audited consolidated and standalone financial results for the year and quarter ended March 31, 2026, with unmodified audit opinions from statutory auditors.
Interim dividend of 10% per equity share (Rs. 1 per share) declared for FY 2025-26, record date May 22, 2026.
Board approved a 1:5 stock split, reducing face value from Rs. 10 to Rs. 2 per share, subject to shareholder approval.
Financial highlights
FY 2026 total income reached INR 1,499.8 crore, up 15.2% year-over-year; EBITDA was INR 343.3 crore, up 14.4%, with a margin of 22.9%.
PAT for the year was INR 194.2 crore; Q4 revenue was INR 387.8 crore, up 15.1%, with EBITDA at INR 89.2 crore (23% margin) and PAT at INR 50.2 crore, up 11.5%.
Consolidated net profit for FY 2025-26 was Rs. 1,941.87 million, compared to Rs. 1,937.54 million last year.
ARPOB grew 11.7% to INR 67,700; ALOS was 3.87 days; bed occupancy for the three established hospitals was 61.2%.
Insurance revenues comprised 55.4% of the revenue mix.
Outlook and guidance
Dombivli hospital expected to reach EBITDA breakeven within two years of operation; insurance empanelment and accreditation processes underway, likely to complete in 6-12 months.
Pune South hospital on track to open in calendar year 2028; Mira Road project to begin excavation by year-end.
Thane hospital expansion pending final regulatory approvals, expected within the financial year.
Scaling bed capacity to 2,900 with new projects in Dombivli, Pune II, Mira-Bhayandar, and BKC, with phased commissioning to optimize capital deployment.
Stock split expected to enhance share liquidity and affordability for retail investors.
- Revenue and EBITDA increased, but PAT fell due to labor code; major hospital expansion underway.JLHL
Q3 25/2610 Apr 2026 - Q1 FY25 saw strong revenue, profit, digital accreditation, and capacity expansion.JLHL
Q1 24/253 Feb 2026 - Strong revenue and profit growth, with major expansion and capital investment underway.JLHL
Q2 24/253 Feb 2026 - Double-digit growth, strong ARPOB, and major expansions, with margin dilution from new hospitals.JLHL
Q2 25/2619 Dec 2025 - FY25 saw strong growth, a recommended dividend, and major expansion and restructuring.JLHL
Q4 24/2519 Dec 2025 - Q1 FY26 revenue and EBITDA rose, but PAT declined on higher costs; volumes and ARPOB up.JLHL
Q1 25/2619 Dec 2025 - Strong growth and expansion, with new hospitals funded by internal accruals and no new debt.JLHL
Q3 24/2519 Dec 2025
Next Jupiter Life Line Hospitals earnings date
Next Jupiter Life Line Hospitals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage